ライフサイエンスコーパス: left atrial enlargement

1 tolic dysfunction, diastolic dysfunction, or left atrial enlargement).

2 cular hypertrophy and a higher prevalence of left atrial enlargement.

3 ion expressed as ventricular hypertrophy and left atrial enlargement.

4 endent of traditional risk factors including left atrial enlargement.

5 to increasing obesity, which correlates with left atrial enlargement.

6 ggesting functional MR can also be caused by left atrial enlargement.

7 , followed by diastolic dysfunction (21.3%), left atrial enlargement (15.3%), systolic dysfunction (6

8 .26 [95% CI, 1.45-3.53]), moderate to severe left atrial enlargement (2 points; OR, 3.43 [95% CI, 2.4

9 remodeling (34%) and hypertrophy (43%), and left atrial enlargement (53%).

10 ive physiology, characterized by progressive left atrial enlargement and diastolic dysfunction with p

11 Atrial arrhythmias may reflect underlying left atrial enlargement and diastolic dysfunction, which

12 e find evidence supporting a causal role for left atrial enlargement and dysfunction on atrial fibril

13 ly, higher Lp(a) levels were associated with left atrial enlargement and dysfunction.

14 d age, female sex, greater right atrial than left atrial enlargement and lower systolic pulmonary art

15 Clinical evaluation revealed the presence of left atrial enlargement and marked left ventricle diasto

16 Mutant mice had left atrial enlargement and Micu2(-/-) cardiomyocytes ha

17 Left atrial enlargement and the ACE DD polymorphism are

18 In the total population, the prevalence of left atrial enlargement and the association between card

19 without HCM diagnoses had clear evidence of left atrial enlargement and/or septal/LV hypertrophy on

20 r hypercontractility, diastolic dysfunction, left-atrial enlargement and left ventricular fibrosis, a

21 traditionally have been used as markers for left atrial enlargement, and both have been associated w

22 tion concomitant with diastolic dysfunction, left atrial enlargement, and cardiac hypertrophy with a

23 alls, decreased left ventricular dimensions, left atrial enlargement, and hyperdynamic left ventricul

24 Diastolic dysfunction, left atrial enlargement, and pulmonary hypertension were

25 inflammation, left ventricular hypertrophy, left atrial enlargement, and subclinical left ventricula

26 ensates for increasing regurgitant volume by left-atrial enlargement, causes left-ventricular overloa

27 ic Csk knockout in mice led to increased AF, left atrial enlargement, fibrosis, and inflammation, phe

28 Left atrial enlargement (> or = 43 mm) was present in 56

29 Eligibility also required either left atrial enlargement (>/=4.4 cm or volume >/=58 mL) o

30 Echocardiography disclosed left atrial enlargement in all affected recipients but n

31 e full spectrum of diagnoses associated with left atrial enlargement in sex-stratified clinical popul

32 , including left ventricular hypertrophy and left atrial enlargement, in addition to pulmonary hypert

33 Left atrial enlargement is a consequence of organic MR,

34 Left atrial enlargement is closely related to the chroni

35 Further, we find that in the community, left atrial enlargement is common and reflects the burde

36 Left atrial enlargement is frequent in degenerative mitr

37 Controversy exists regarding whether left atrial enlargement (LAE) is a predictor of stroke/s

38 ), isolated LV diastolic dysfunction (LVDD), left atrial enlargement (LAE), LV hypertrophy (LVH), and

39 on: HR, 6.64; 95% CI, 2.29-19.24; P < .001), left atrial enlargement (LAE; HR, 3.63; 95% CI, 1.55-8.4

40 For patients with left atrial enlargement, left atrial size decreased sign

41 estrictive: 1 echocardiographic abnormality (left atrial enlargement, left ventricle hypertrophy, dia

42 hy-based diabetic cardiomyopathy (echo-DbCM; left atrial enlargement, left ventricular hypertrophy, o

43 rutinib for 4 weeks results in inducible AF, left atrial enlargement, myocardial fibrosis, and inflam

44 The frequent left atrial enlargement of DMR as measured by LAVI in ro

45 moderate or greater mitral regurgitation or left atrial enlargement or atrial fibrillation (stage 2)

46 New-onset atrial fibrillation, left atrial enlargement, pulmonary hypertension, and exe

47 etely independent of age, hypertension, sex, left atrial enlargement, valvular heart disease, left ve

48 nce of LV hypertrophy was 21%, prevalence of left atrial enlargement was 83%, prevalence of elevated

49 In the total population, left atrial enlargement was common, with a prevalence of